News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

California Stem Cell, Inc. and Stemina Biomarker Discovery Announce Collaboration to Validate Effectiveness of Human Embryonic Stem Cell-Derived Cardiomyocyte Progenitors for Use in Predictive Toxicology


9/17/2009 10:06:30 AM

IRVINE, Calif.--(BUSINESS WIRE)--Collaboration between California Stem Cell, Inc. (CSC) and Stemina Biomarker Discovery on a study using CSC’s 96-well CardioPlateTM containing high purity human embryonic stem cell (hESC)-derived cardiomyocyte progenitor cells, has demonstrated that it can be used as a model system for investigating and predicting drug induced cardiotoxicity, officials from the firms announced today.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES